TOTAL VOLUME:

$154.5b

24H VOL:

$271,200,656

24H TRANSACTIONS:

2,984,640,614

OPEN INTEREST:

$1,922,627,141

420,368

Markets across

40,352

events

MATCHED EVENTS:

4,484

PLATFORM COVERAGE:

5

Polymarket:

37%

VS.

Kalshi:

63%

BETA
Dashboards
Tour
All
What will Johnson & Johnson say during their next earnings call?
kalshi

What will Johnson & Johnson say during their next earnings call?

Volume:
$81,683

Ottava

 - Kalshi

Ottava - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Oct 13, 2026

Closed: Oct 13, 10:37 AM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Ottava

View
100%
2%
Yes 100¢No 0¢
—
N/A
$10,594
N/A
N/A
$6,547
4mo 4w
Yes
kalshi

Procedure

100%
5%
Yes 100¢No 0¢
—
N/A
$9,963
N/A
N/A
$7,141
4mo 4w
Yes
kalshi

Tecvayli

100%
10%
Yes 100¢No 0¢
—
N/A
$7,570
N/A
N/A
$4,208
4mo 4w
Yes
kalshi

Rybrevant

100%
1%
Yes 100¢No 0¢
—
N/A
$5,573
N/A
N/A
$3,532
4mo 4w
Yes
kalshi

China

100%
8%
Yes 100¢No 0¢
—
N/A
$5,363
N/A
N/A
$3,427
4mo 4w
Yes
kalshi

Litigation

100%
27%
Yes 100¢No 0¢
—
N/A
$4,599
N/A
N/A
$3,490
4mo 4w
Yes
kalshi

Caplyta

100%
7%
Yes 100¢No 0¢
—
N/A
$4,573
N/A
N/A
$3,238
4mo 4w
Yes
kalshi

Tariff

100%
15%
Yes 100¢No 0¢
—
N/A
$3,747
N/A
N/A
$2,833
4mo 4w
Yes
kalshi

Firefly Bio

100%
4%
Yes 100¢No 0¢
—
N/A
$3,225
N/A
N/A
$3,188
4mo 4w
Yes
kalshi

Darzalex Faspro

100%
51%
Yes 100¢No 0¢
—
N/A
$3,175
N/A
N/A
$2,630
4mo 4w
Yes
kalshi

AI / Artificial Intelligence

0%
59%
Yes 0¢No 100¢
—
N/A
$14,868
N/A
N/A
$12,553
4mo 4w
No
kalshi

Vaccine

0%
12%
Yes 0¢No 100¢
—
N/A
$2,470
N/A
N/A
$2,132
4mo 4w
No
kalshi

Halda Therapeutics

0%
39%
Yes 0¢No 100¢
—
N/A
$2,003
N/A
N/A
$1,441
4mo 4w
No
kalshi

Nipocalimab / Lupus

0%
43%
Yes 0¢No 100¢
—
N/A
$1,804
N/A
N/A
$1,522
4mo 4w
No
kalshi

Administration

0%
Yes 0¢No 100¢
—
N/A
$1,200
N/A
N/A
$945
4mo 4w
No
kalshi

Gene Therapy

0%
Yes 0¢No 100¢
—
N/A
$956
N/A
N/A
$920
4mo 4w
No
Total markets: 16

Description

During Johnson & Johnson's upcoming earnings call, participants will discuss various topics relevant to the company's operations and strategic focus. The call may touch on product developments, financial performance, regulatory matters, and other business priorities, reflecting the company's current landscape and future outlook.

Kalshi

The event evaluates whether specific predefined terms are mentioned by any Johnson & Johnson representative during their next earnings call scheduled for October 13, 2026, including the question-and-answer segment. Each market corresponds to a unique term or phrase, and the outcome for each market is determined by whether that exact term (or its plural/possessive form) is uttered. Resolution relies primarily on video recordings of the call; if video review fails to achieve consensus among Kalshi employees, official transcripts from designated news publications will be used as the fallback. Grammatical variations or inflections do not qualify for payout. Kalshi explicitly disclaims any formal affiliation with Johnson & Johnson, and all referenced trademarks remain the property of their respective owners.

Frequently asked questions

On Kalshi, the dashboard for the Johnson & Johnson earnings call tracks the current odds of various outcomes related to what will be discussed during the call. You'll find the implied probabilities for each outcome, a price history showing how those probabilities have changed over time, and the 24-hour trading volume, which currently stands at $16,349. Total volume for this market is $81,683. This allows traders to gauge market sentiment and identify potential opportunities as the earnings call approaches. The dashboard provides a dynamic view of expectations surrounding key topics.

Currently, prediction market odds reflect a collective forecast of what topics will be addressed during the Johnson & Johnson earnings call. These odds represent what traders believe will happen, based on their own research and insights. This differs from traditional analyst forecasts, which are typically based on financial modeling and company reports. While analysts may predict specific financial results, this market focuses on the content of the call itself – what themes and issues management will highlight. It's interesting to see how this market's expectations align with, or diverge from, those of financial analysts covering the company.

On Kalshi, this market is priced using a continuous double auction. Traders buy and sell contracts representing different outcomes related to the Johnson & Johnson earnings call, and the prices of these contracts fluctuate based on supply and demand. As more traders believe a particular outcome is likely, the price of the corresponding contract will increase, and vice versa. On Kalshi, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. The market price reflects the collective wisdom of the crowd, providing a real-time assessment of probabilities. This dynamic pricing mechanism allows for efficient discovery of information and a constantly updated forecast.

This market resolves around Mar 31, 2027, with the outcome confirmed once the content of the Johnson & Johnson earnings call is verifiable from credible public reporting. The resolution will be based on a review of the official transcript or recording of the call, determining which topics were discussed and to what extent. The market will settle to 100 for the outcome that best reflects what was said during the call, as determined by a review of the call transcript. Traders should monitor news sources and the company's investor relations website for updates as the resolution date approaches.

Several signals or events could significantly move this market before it resolves. Any pre-earnings announcements from Johnson & Johnson, such as regulatory updates or preliminary financial results, could shift expectations. Analyst reports and media coverage leading up to the call can also influence trading activity. Unexpected economic data releases or broader market trends impacting the healthcare sector could also play a role. Finally, any news related to Johnson & Johnson's key products or ongoing litigation could cause traders to reassess their positions and adjust the odds in this market.